Performance of the dentogingival junction with mta and biodentine on the treatment of invasive cervical resorptions. A literature review and case report

• Beatriz Gión-Guerra ^[1] ; Pablo Pérez-Lanza ^[1] ; Pedro Almiñana-Pastor ^[1] ; Pau Micó-Martínez ^[1] ; Francisco M. Alpiste-Illueca ^[1] ; Andrés López-Roldán ^[1]
  1. [1] Universitat de València

     Universitat de València

     Valencia, España

     
• Localización: Journal of Clinical and Experimental Dentistry, ISSN-e 1989-5488, Vol. 13, Nº. 1 (January), 2021, págs. 95-98
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Invasive cervical resorption (ICR) is an uncommon phenomenon (0.1%), however, it represents a challenge to the structural and functional integrity of the dentogingival junction, as well as a risk for the survival of the affected tooth. They are characterized by their location and invasive character, being able to appear in any tooth of the permanent dentition. It shows up after the damage to the cervical insertion apparatus, leaving the pulp without participation in the origin of the lesion. They may appear just below the junctional epithelium or at a more apical level.

    The MTA® (Dentsply, Tulsa dental, Tulsa OK) and the Biodentine® (Septodent, Saint Maur of Fossés, France) are two biomaterials that have demonstrated the ability to promote the neoformation of cement so they are considered an alternative in the treatment of the ICR. This article presents an ICR clinical cases treated with these biomaterials, in which favorable post-operative healing is observed.